Keywords
Prevalence
Late diagnosis
Access to health services
Hospital costs
How to Cite
Copyright © | All rights reserved.
The journal holds the exclusive copyright for the publication of this article under the terms of Brazilian law 9610/98.
Partial reproduction
The use of parts of the texts, figures and questionnaire of the article is free, being mandatory the citation of the authors and journal.
Total reproduction
It is expressly prohibited and must be authorized by the journal.
Abstract
Objective: To analyze the prevalence, staging at diagnosis, and access to treatment for colon cancer in Brazil using DATASUS data from 2020 to 2024. Methods: This is a descriptive cross-sectional study based on secondary DATASUS records, analyzing variables such as sex, age, staging, therapeutic modalities, and regional distribution. Results: Between 2020 and 2024, 114,722 cases of colon cancer were diagnosed, with a predominance of females (52.33%) and a mean age of 59 years. Most diagnoses occurred at advanced stages (80.22%), and 36.13% of patients had no registered treatment. The average time between diagnosis and treatment was 51 days. The Southeast region had the highest number of hospitalizations and healthcare costs, highlighting regional disparities. Conclusion: Late diagnosis and limited access to treatment negatively impact clinical and economic outcomes, emphasizing the need for public policies focused on early screening and regional equity in colon cancer management.
References
ALTAF A, et al. Impact of patient, hospital, and operative characteristics relative to social determinants of health: compliance with national comprehensive cancer network guidelines for colon cancer. Journal of Gastrointestinal Surgery, 2024; 28(9): 1463-1471.
BENSON AB, et al. Colon Cancer, Version 2.2021, NCCN Clinical Practice Guidelines in Oncology. Journal of the National Comprehensive Cancer Network, 2021; 19(3): 329-359.
BENSON AB, et al. Colon Cancer, Version 3.2024, NCCN Clinical Practice Guidelines in Oncology. Journal of the National Comprehensive Cancer Network, 2024; 22(2): 240029.
BOLAND GM, et al. Association between adherence to National Comprehensive Cancer Network treatment guidelines and improved survival in patients with colon cancer. Cancer, 2012; 119(8): 1593-1601.
CHEN H, et al. Development and validation of a five-immune gene prognostic risk model in colon cancer. BMC Cancer, 2020; 20(1): 395.
CHOTTANAPUND S, et al. Modifiable factors and colon cancer risk in Thai population. Asian Pacific Journal of Cancer Prevention, 2021; 22(1): 37-43.
COSTA IGM, et al. Análise epidemiológica da neoplasia maligna de pâncreas no Brasil: internações, óbitos e taxa de mortalidade. Brazilian Journal of Implantology and Health Sciences, 2024; 6(7): 1007-1021.
FABREGAS JC, et al. Clinical updates for colon cancer care in 2022. Clinical Colorectal Cancer, 2022; 21(3): 198-203.
GASHTI SM, et al. Câncer colorretal: principais complicações e a importância do diagnóstico precoce. Revista Eletrônica Acervo Saúde, 2021; 13(4): 6888.
HALLA M, et al. Cost savings of developmental screenings: evidence from a nationwide program. Journal of Health Economics, 2016; 49: 120-135.
KHAN SZ, et al. Challenges in the management of colorectal cancer in low- and middle-income countries. Cancer Treatment and Research Communications, 2023; 35: 100705.
LIMA MAN e VILLELA DAM. Fatores sociodemográficos e clínicos associados ao tempo para o início do tratamento de câncer de cólon e reto no Brasil, 2006-2015. Cadernos de Saúde Pública, 2021; 37(5): 214919.
LU L, et al. A global assessment of recent trends in gastrointestinal cancer and lifestyle-associated risk factors. Cancer Communications, 2021; 41(11): 1137-1151.
RODRÍGUEZ-FRAILE M, et al. FDG PET/TC en el cáncer colorrectal. Revista Española de Medicina Nuclear e Imagen Molecular, 2020; 39(1): 57-66.
SÁNCHEZ-GUILLÉN L e ARROYO A. Immunonutrition in patients with colon cancer. Immunotherapy, 2020; 12(1): 5-8.
SECKIM JS, et al. Análise do perfil epidemiológico de internações por câncer de cólon no Brasil entre 2013 e 2023. Brazilian Journal of Implantology and Health Sciences, 2024; 6(9): 1132-1138.
SILVA AA, et al. Morbimortalidade hospitalar por câncer colorretal no Brasil, no período de 2008 a 2016. Revista Eletrônica Acervo Científico, 2019; 5: 939.
SOUZA LR, et al. Perfil epidemiológico dos casos de câncer colorretal notificados na região sul do Brasil. Revista Eletrônica Acervo Saúde, 2024; 24(3): 15088.
STOFFEL EM, et al. Epidemiology and mechanisms of the increasing incidence of colon and rectal cancers in young adults. Gastroenterology, 2020; 158(2): 341-353.
TONINI V e ZANNI M. Why is early detection of colon cancer still not possible in 2023? World Journal of Gastroenterology, 2024; 30(3): 211-224.